BEHCET SYNDROME
Clinical trials for BEHCET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new BEHCET SYNDROME trials appear
Sign up with your email to follow new studies for BEHCET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Behcet's patients: drug trial shows symptom relief for hard-to-treat cases
Disease control CompletedThis study tested a drug called TA-650 (similar to infliximab) in 18 adults with Behcet's disease who had serious complications like eye, brain, or gut problems that didn't get better with standard treatments. Participants received the drug by IV at weeks 0, 2, and 6, then every …
Matched conditions: BEHCET SYNDROME
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for tough Behcet's: drug shows promise in small trial
Disease control CompletedThis study tested the drug upadacitinib in 27 adults with Behcet's syndrome that did not improve with standard treatments. The goal was to see if the drug could reduce symptoms and prevent new disease activity. Results showed that many patients experienced improvement, but the dr…
Matched conditions: BEHCET SYNDROME
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated May 18, 2026 12:02 UTC